Supernus Pharmaceuticals SUPN reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Supernus Pharmaceuticals their estimated earnings by 73.91%, reporting an EPS of $0.4 versus an estimate of $0.23, which surprised analysts.
Revenue was up $6,671,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.23, which was followed by a 2.17% drop in the share price the next day.
Here's a look at Supernus Pharmaceuticals's past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.20 | 0.24 | 0.52 | 0.30 |
| EPS Actual | 0.43 | 0.11 | 0.57 | 0.74 |
| Revenue Estimate | 134.87M | 129.20M | 146.19M | 130.66M |
| Revenue Actual | 141.33M | 130.93M | 143.56M | 155.13M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
